Clinical trial
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
NCT00177190 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177190 |
|---|---|
| Title | In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) |
| Official title | In Vitro Evaluation of Immune Responses in CTCL |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides |
| Enrollment | 8 |
| Start date | Jun 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | May 28, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: